Personalis, Inc. (ticker: PSNL) is an NASDAQ-listed services-medical laboratories company. DredgeCap's structured extraction of PSNL's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. PSNL reported $15.47M in revenue and -$30.03M for the period ending 2026-03-31, with operating cash flow of -$22.48M. Cash and equivalents stood at $73.59M (up 3.7% year-over-year). Total assets of $325.39M exceed total liabilities of $70.63M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
PSNL SEC Filings
Full cached SEC EDGAR filing history for PSNL, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.